1. Home
  2. VVOS

as 07-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical Specialities

Nasdaq

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Founded: N/A Country:
United States
United States
Employees: N/A City: LITTLETON
Market Cap: 6.8M IPO Year: 2020
Target Price: N/A AVG Volume (30 days): 77.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -10.93 EPS Growth: N/A
52 Week Low/High: $1.91 - $48.79 Next Earning Date: 08-12-2024
Revenue: $13,363,000 Revenue Growth: -17.70%
Revenue Growth (this year): 14.17% Revenue Growth (next year): 19.16%

VVOS Daily Stock ML Predictions

Share on Social Networks: